Zhinuan Yu

Corporate VP, Biometrics & Regulatory Enabling Functions at Antengene

Dr. Yu has over 20 years of experience in the pharmaceutical industry and led the statistical support at Celgene for multiple high-priority programs, including thalidomide, lenalidomide, pomalidomide, and bb2121 (CAR-T).

Org chart

Manager

Jay Mei

Founder, Chairman & CEO

Peers

Ariel Guo

Senior Director, Pipeline Strategy & Project Leadership

Yiteng Liu

COO

Thomas Karalis

Corporate VP & Head, Asia Pacific Region

Teams

Leadership Team

9 members

Timeline

Corporate VP, Biometrics & Regulatory Enabling Functions
Current role

View in org chart